Pharma Industry
Industry: Email Alert RSS FeedBIOTECH Patent News
View more issues:
Articles in July, 2007 issue of BIOTECH Patent News
- Nitta Gelatin obtains United States patent.
- Koronis announces issuance of United States patent for therapeutic in development for treatment of HIV.
- Bayer Cropscience obtains United States patent.
- Clarient and Health Discovery initiate alliance with licensing agreement for new molecular diagnostic test for prostate cancer.(Company overview)
- Industry Foundation of Chonnam National University obtains United States patent.
- Proteome Sciences obtains patent for isobaric tandem mass tags.
- Monogram Biosciences obtains United States patent.
- Senomyx expands patent protection for discovery of novel sweet and savory flavor ingredients.
- Rosetta issued patent relating to MicroRNAs.(Company overview)
- Cell Therapeutics announces agreement to acquire Systems Medicine and Gains Global Rights to Brostallicin, a new cancer killing agent.
- Takeda obtains United States patent.
- Aho obtains United States patent.
- Monsanto patents asserted against American farmers rejected in reexamination.
- Bayer CropScience obtains United States patent.
- Neurocrine in-licenses clinical compound valnoctamide stereoisomer for neurological and psychiatric diseases.
- Rajavashisth obtains United States patent.
- Court dismisses Gen-Probe court action against Digene.
- Xenomics announces issuance of a European patent that covers use of transrenal nucleic acid technology for prenatal diagnostics.
- Beckman Instruments obtains United States patent.
- Schering-Plough announces licensing of Acadesine, an investigational agent being studied for prevention of complications from cardiac surgery potentially life-saving agent strengthens company's cardiovascular late-stage development portfolio.
- Fred Hutchinson Cancer Research Center obtains United States patent.
- Schering obtains United States patent.
- BioMedical Enterprises announces patent infringement lawsuit stay ordered.(Company overview)
- AGA Medical wins patent infringement lawsuit against Occlutech.
- University of California obtains United States patent.
- National Stem Cell announces patent application for newly discovered cellular derived biomaterials for tissue repair and wound care applications.
- University of Queensland of St. Lucia obtains United States patent.
- University of Florida obtains United States patent.(Brief article)
Brought to you by CBS MoneyWatch.com
- Best- and Worst-Paid College Degrees
- 6 Things You Should Never Do on Twitter or Facebook
- How Much Sleep Do You Really Need?
- 6 Big Myths about Gas Mileage
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Most Recent Technology Articles
Most Recent Technology Publications
Most Popular Technology Articles
- BizRate to monitor in-store customer satisfaction for Office Depot stores - Market Intelligence
- Speed control of separately excited DC motor
- Effects of creative, educational drama activities on developing oral skills in primary school children
- Political stability and economic growth in Asia
- Failed businesses in Japan: a study of how different companies have failed, and tips on how to succeed, in the Japanese market



